Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Sep 30, 2025 | (Q6)Mar 31, 2025 | (FY)Sep 30, 2024 | (Q6)Mar 31, 2024 | (FY)Sep 30, 2023 | (Q6)Mar 31, 2023 | (FY)Sep 30, 2022 | (Q6)Mar 31, 2022 | (FY)Sep 30, 2021 | (Q6)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ---- | -100.57%-278.06K | ---- | 180.55%48.51M | ---- | -47.95%-60.23M | -132.79%-25.15M | -176.54%-40.71M | 246.39%76.71M | 207.75%53.18M |
| Special items of operating revenue | 6,357.92%145.94M | ---- | 97.52%-2.33M | ---- | ---93.88M | ---- | ---- | ---- | ---- | ---- |
| Operating income | 6,357.92%145.94M | -100.57%-278.06K | 97.52%-2.33M | 180.55%48.51M | -273.30%-93.88M | -47.95%-60.23M | -132.79%-25.15M | -176.54%-40.71M | 246.39%76.71M | 207.75%53.18M |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Administrative expenses | -0.36%-10.17M | 33.19%-5.07M | 30.88%-10.13M | 9.93%-7.59M | 13.97%-14.66M | -47.26%-8.43M | -47.00%-17.04M | -3.02%-5.72M | 31.30%-11.59M | 37.45%-5.55M |
| Impairment and provision | 364.44%1.98M | ---- | 97.61%-750.4K | -286.50%-19.11M | 16.09%-31.46M | 375.86%10.25M | -704.87%-37.49M | -22.27%2.15M | 88.54%-4.66M | --2.77M |
| -Other impairment is provision | 364.44%1.98M | ---- | 97.61%-750.4K | -286.50%-19.11M | 16.09%-31.46M | 375.86%10.25M | -704.87%-37.49M | -22.27%2.15M | 88.54%-4.66M | --2.77M |
| Special items of operating profit | -330.24%-3.08M | ---- | 78.99%-716.71K | -2,185.99%-400.51K | 36.52%-3.41M | 100.49%19.2K | -236.61%-5.37M | -58.82%-3.9M | -39.66%3.93M | -47.77%-2.45M |
| Operating profit | 1,066.81%134.67M | -124.98%-5.35M | 90.29%-13.93M | 136.67%21.41M | -68.61%-143.41M | -21.21%-58.39M | -232.09%-85.05M | -200.47%-48.17M | 162.27%64.39M | 180.04%47.94M |
| Financing cost | 44.00%-3.58M | 41.84%-1.88M | -4.88%-6.4M | -135.92%-3.24M | -98.52%-6.1M | 12.07%-1.37M | -84.28%-3.07M | -72.44%-1.56M | 19.46%-1.67M | 13.22%-904.49K |
| Earning before tax | 744.92%131.09M | -139.77%-7.23M | 86.40%-20.33M | 130.42%18.18M | -69.66%-149.51M | -20.17%-59.76M | -240.50%-88.13M | -205.72%-49.73M | 159.46%62.72M | 177.19%47.04M |
| Tax | ---- | ---- | -9.06%410.65K | --205.33K | --451.56K | ---- | ---- | ---- | ---- | ---- |
| After-tax profit from continuing operations | 758.22%131.09M | -139.33%-7.23M | 86.64%-19.92M | 130.76%18.38M | -69.14%-149.06M | -20.17%-59.76M | -240.50%-88.13M | -205.72%-49.73M | 159.46%62.72M | 177.19%47.04M |
| Earning after tax | 758.22%131.09M | -139.33%-7.23M | 86.64%-19.92M | 130.76%18.38M | -69.14%-149.06M | -20.17%-59.76M | -240.50%-88.13M | -205.72%-49.73M | 159.46%62.72M | 177.19%47.04M |
| Profit attributable to shareholders | 758.22%131.09M | -139.33%-7.23M | 86.64%-19.92M | 130.76%18.38M | -69.14%-149.06M | -20.17%-59.76M | -240.50%-88.13M | -205.72%-49.73M | 159.46%62.72M | 177.19%47.04M |
| Basic earnings per share | 680.00%0.29 | -136.76%-0.0161 | 85.71%-0.05 | 130.80%0.0438 | -66.67%-0.35 | -16.08%-0.1422 | -216.67%-0.21 | -188.32%-0.1225 | 147.37%0.18 | 162.70%0.1387 |
| Diluted earnings per share | 680.00%0.29 | -136.76%-0.0161 | 85.71%-0.05 | 130.80%0.0438 | -66.67%-0.35 | -16.08%-0.1422 | -223.53%-0.21 | -190.54%-0.1225 | 144.74%0.17 | 161.17%0.1353 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Guocheng Certified Public Accountants Co., Ltd. | -- | Guocheng Certified Public Accountants Co., Ltd. | -- | Debo Certified Public Accountants Co., Ltd. | -- | Debo Certified Public Accountants Co., Ltd. | -- | Debo Certified Public Accountants Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.